Tamoxifen-associated endometrial pathology in menopausal asymptomatic women with breast cancer, sonographic and hysteroscopic correlates

Italian Journal of Gynaecology and Obstetrics

Volumn 15, Issue 1, 2003, Pages 47-55

  Garuti, G ^a   Cellani, F ^a   Colonnelli, M ^a   Centinaio, G ^a   Garzia, D ^a   Gonfiantini, C ^a   Luerti, M ^a  

^a Lodi Hospital   (Italy)

Author keywords

Breast cancer; Endometrial cancer; Endometrium; Hysteroscopy; Tamoxifen; Transvaginal ultrasonography

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CALCULATION; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOMETRIAL DISEASE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOSCOPIC POLYPECTOMY; FEASIBILITY STUDY; FEMALE; GENERAL ANESTHESIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; PATIENT SELECTION; POLYP; PREVALENCE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; THICKNESS; TRANSVAGINAL ECHOGRAPHY;

EID: 0038746883     PISSN: 11218339     EISSN: 23850868     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. An overview of the randomized trials. Lancet 1998; 351: 1451-67.
2. Fisher B, Dignom J, Walmark N. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 1999; 353: 1993-000.
3. Fisher B, Costantino JP, Wickerham DL. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study J Natl Cancer Inst 1998; 90: 1371-88.
4. Stearns V, Gelman EP. Does tamoxifen cause cancer in humans? J Clin Oncol 1998; 16: 779-92.
5. Schwartz LB, Krey L, Demopoulos R, Goldstein SR, Nachtigall LE, Mittal K. Alterations in steroid hormone receptor in the tamoxifen treated endometrium. Am J Obstet Gynecol 1997; 176: 129-37.
6. Neven P. Endometrial changes in patients on tamoxifen. The Lancet 1995; 346: 1292
7. DeMuylder X, Neven P, DeSomer M. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 1991; 36: 127-00.
8. Fisher B, Costantino JP, Redmond CK. Endometrial cancer in tamoxifen treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project B-14. J Natl Cancer Inst 1994; 86: 527-37.
9. VanLeeuwen FE, Benraadt J, Coehergh IWW. Risk of endometrial cancer after tamoxifen treatment of breast cancer. The Lancet 1994; 343: 448-52.
10. Mignotte H, Lasset C, Bonadona V. Iatrogenic risk of endometrium after treatment for breast cancer in a large french case-control study. Int J Cancer 1998; 76: 325-00.
11. Neven P, Vernaeve H. Guidelines for monitoring patients taking tamoxifen treatment. Drug Safety 2000; 22: 1-11.
12. Gerber B, Krause A, Muller H, Reimer T, Kulz T, Makovitzky J, Kundt G, Friese K. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol 2000; 18: 3464-00.
13. Love CDB, Muir BB, Scrimgeaur JB, Leonard RCF, Dillon P, Dixon JM. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999; 17: 2050-4.
14. Garuti G, Cellani F, Grossi F, Colonnelli M, Centinaio G, Luerti M. Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake. Gynecol Oncol 2002; 86: 323-9.
15. Garuti G, Sambruni I, Colonnelli M. Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women. J Am Assoc Gynecol Laparosc 2001; 8: 207-13.
16. Loffer FD. Hysteroscopy with selective endometrial sampling compared with dilatation and curettage for abnormal uterine bleeding: the value of a negative hysteroscopic view. Obstet Gynecol 1989; 73: 16-0.
17. Buckley CH, Fox H. Biopsy pathology of the endometrium. Biopsy Pathology Series 14, London: Chapman & Hall Medical, 1989.
18. Ceci O, Bettocchi S, Morello F, Di Venere R, Pellegrino AR, Laricchia L, Vimercati A. Hysteroscopic evaluation of the endometrium in postmenopausal women taking tamoxifen. J Am Assoc Gynecol Laparosc 2000; 7: 185-9.
19. Bertelli G, Valenzano M, Costantini S, Rissone R, Angiolini C, Signorini A, Gustavino C. Limited value of sonohysterography for endometrial screening in asymptomatic postmenopausal patients treated with tamoxifen. Gynecol Oncol 2000; 78: 275-7.
20. Timmermann D, Deprest J, Bournet T, Van der Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 1998; 179: 62-0.
21. Franchi M, Ghezzi F, Donadello N, Zanaboni F, Beretta P, Bolis P. Endometrial thickness in tamoxifen treated patients: an independent predictor of endometrial disease. Obstet Gynecol 1999; 93: 1004-8.
22. Cohen I, Azaria R, Shapira J, Yigael D, Tepper R. Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen treated women. Cancer 2002; 94: 3101-6.
23. Neven P, DeMuylder X, VanBelle Y, VanHooff I, Vanderick G. Longitudinal hysteroscopic follow-up during tamoxifen treatment. The Lancet 1998; 351: 36
24. Berlière M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 1998; 91: 40-4.
25. Adami HO, Krusemo UB, Bergkvist L. On the age dependent association between cancer of the breast and of the endometrium. A nationwide cohort study. Br J Cancer 1987; 55: 77-0.
26. Randolph J, Ying Y, Maier D. Comparison of real time ultrasonography, hysterosalpingography and laparoscopy/hysteroscopy in the evaluation of uterine abnormalities and tubal patency. Fertil Steril 1986; 46: 828-32.
27. McElrath T, Anderson P, Fields A, Somma L, Gross S, Runowicz C. Saline infusion sonography: a diagnostic and therapeutic intervention for patients on tamoxifen. Obstet Gynecol 2000; 95: 53-4.
28. Elhelw B, Ghorah MNM, Farrag SH. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen. Int J Gynecol Obstet 1999; 67: 81-6.
29. Hann LE, Gretz EM, Bach AM, Francis SM. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen. Am Roetgenol 2000; 177: 593-7.
30. Gimpelson RJ, Rappold HO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol 1988; 152: 489-92.
31. Nagele F, O'Connors H, Davies A, Badaway A, Mohamed H, Magos A. A 2500 out patients diagnostic hysteroscopies. Obstet Gynecol 1996; 1: 87-92
32. Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 1994; 170: 447-51.